Medlive Technology Co., Ltd. (2192.HK)
- Previous Close
11.860 - Open
11.960 - Bid 11.720 x --
- Ask 11.760 x --
- Day's Range
11.620 - 11.960 - 52 Week Range
6.610 - 16.880 - Volume
788,000 - Avg. Volume
5,791,261 - Market Cap (intraday)
8.619B - Beta (5Y Monthly) 0.57
- PE Ratio (TTM)
25.57 - EPS (TTM)
0.460 - Earnings Date Mar 24, 2025
- Forward Dividend & Yield 0.28 (2.38%)
- Ex-Dividend Date May 12, 2025
- 1y Target Est
15.94
Medlive Technology Co., Ltd. operates an online professional physician platform in Mainland China and internationally. The company's precision marketing and corporate solution provides digital marketing, digital detailing, digital marketing consultation, digital content creation, application software development, and other relevant services. Its medical knowledge solution offers medical education and clinical decision support, including licensing software to physicians, other registered users, such as other healthcare professionals and pharmaceutical companies. The company's intelligent patient management solution provides single disease management services, including disease knowledge dissemination and treatment compliance monitoring;patient education services comprising content development, application software development, and other related services; and chronic disease management services for Parkinson's lymphoma, stroke and diabetes, and breast cancer, lung cancer, ovarian cancer. In addition, it is involved in research and development services; internet hospital services; publication and planning services for medicine guidelines and medical consensus; organizing medical exhibition conferences; provision of medical services; and provision of research services to pharmaceutical companies. The company was formerly known as Kingyee Co., Limited and changed its name to Medlive Technology Co., Ltd. in 2021. The company was founded in 1996 and is headquartered in Beijing, China.
www.medlive.cn747
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 2192.HK
View MorePerformance Overview: 2192.HK
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2192.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2192.HK
View MoreValuation Measures
Market Cap
8.62B
Enterprise Value
4.19B
Trailing P/E
25.59
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
14.44
Price/Book (mrq)
1.67
Enterprise Value/Revenue
6.99
Enterprise Value/EBITDA
10.94
Financial Highlights
Profitability and Income Statement
Profit Margin
56.43%
Return on Assets (ttm)
1.47%
Return on Equity (ttm)
6.95%
Revenue (ttm)
558.45M
Net Income Avi to Common (ttm)
315.15M
Diluted EPS (ttm)
0.460
Balance Sheet and Cash Flow
Total Cash (mrq)
4.15B
Total Debt/Equity (mrq)
0.47%
Levered Free Cash Flow (ttm)
46.04M